Victory Capital Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-237,024
Closed -$42M 3712
2020
Q1
$42M Buy
237,024
+117,957
+99% +$22.2M 0.04% 635
2019
Q4
$22.8M Sell
119,067
-1,952
-2% -$352K 0.03% 780
2019
Q3
$20.4M Sell
121,019
-98,966
-45% -$16.1M 0.03% 783
2019
Q2
$36.8M Sell
219,985
-270,020
-55% -$37.4M 0.07% 405
2019
Q1
$71.7M Sell
490,005
-2,009
-0.4% -$291K 0.16% 163
2018
Q4
$65.8M Buy
492,014
+53,413
+12% +$8.76M 0.17% 163
2018
Q3
$83.5M Sell
438,601
-11,257
-3% -$2.07M 0.17% 150
2018
Q2
$75M Buy
449,858
+646
+0.1% +$104K 0.16% 165
2018
Q1
$75.6M Buy
449,212
+47,067
+12% +$7.89M 0.16% 173
2017
Q4
$65.8M Buy
402,145
+54,208
+16% +$9.73M 0.14% 215
2017
Q3
$71.3M Buy
347,937
+79,165
+29% +$18.4M 0.16% 185
2017
Q2
$65.3M Sell
268,772
-165,889
-38% -$39M 0.15% 205
2017
Q1
$104M Sell
434,661
-164,244
-27% -$38.2M 0.25% 105
2016
Q4
$126M Buy
598,905
+137,228
+30% +$28.4M 0.32% 55
2016
Q3
$106M Buy
461,677
+437,224
+1,788% +$107M 0.3% 71
2016
Q2
$5.65M Buy
24,453
+11,509
+89% +$2.65M 0.02% 553
2016
Q1
$3.47M Sell
12,944
-292
-2% -$83.6K 0.01% 606
2015
Q4
$4.14M Sell
13,236
-4,034
-23% -$1.2M 0.02% 557
2015
Q3
$4.69M Sell
17,270
-8,440
-33% -$2.59M 0.02% 552
2015
Q2
$7.8M Buy
25,710
+4,975
+24% +$1.48M 0.03% 522
2015
Q1
$6.17M Sell
20,735
-590
-3% -$168K 0.02% 522
2014
Q4
$5.49M Buy
+21,325
New +$5.33M 0.02% 538

Other funds holding AGN

Victory Capital Management's AGN Position: Q2 2020 in Review

Victory Capital Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 237,024 shares — an estimated $42M sold.

Victory Capital Management first reported a position in AGN in Q4 2014 and held it in 22 quarters. The position peaked at $126M in Q4 2016. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Victory Capital Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Victory Capital Management sold 237,024 Allergan plc shares in Q2 2020, an estimated $42M.
  • Victory Capital Management first reported a position in Allergan plc in Q4 2014 and held it in 22 quarters.
  • Victory Capital Management's Allergan plc position peaked at $126M in Q4 2016.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Victory Capital Management's 13F filing for Q2 2020, filed 7 Aug 2020.